Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China flag China · Delayed Price · Currency is CNY
3.890
+0.030 (0.78%)
Sep 30, 2026, 3:04 PM CST

SHE:300194 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,6571,7382,3912,6482,4222,453
Revenue Growth
-11.81%-27.31%-9.68%9.33%-1.28%3.58%
Gross Profit
603.21607.611,2181,3671,3551,517
Operating Income
86.0856.69248.55184.51100.24147.59
Net Income
59.6577279.84231.87204.61-296.91
Earnings Per Share
0.050.060.240.190.17-0.25
EPS Growth
-70.98%-75.00%26.32%11.77%--

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Northeast China
28.1967.3889.41108.46152.74
Northern china
157.75239.43318.08279.12278.85
East China
655.96849.47851.69753.57749.9
Southern China
130.63192.55214.83207.11213.96
Central China
348.56487.81459.93434.04364.81
Northwestern Region
52.2674.2680.73195.3374.34
Southwest Region
227.73330.52477.85274.6389.09
Export and Others
77.0466.9578.28125.3164.76
Unallocated
60.1783.176.9444.2264.71
Total
1,7382,3912,6482,4222,453

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
899.881,037876.32996.89703.741,002
Total Debt
595.02800.42705.78892.86714.2906.03
Net Cash (Debt)
304.87236.24170.54104.03-10.4595.96
Net Cash Growth
298.80%38.52%63.93%---68.79%
Net Cash Per Share
0.230.180.150.09-0.010.08

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
435.15312.32303.59328.98339.5257.13
Capital Expenditures
-82.88-108.43-241.79-215.68-383.1-413.03
Free Cash Flow
352.27203.8961.8113.3-43.6-155.91
Free Cash Flow Growth
-229.94%-45.46%---

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
36.40%34.96%50.91%51.63%55.97%61.85%
Operating Margin
5.20%3.26%10.39%6.97%4.14%6.02%
Pretax Margin
4.27%4.79%13.05%10.97%7.82%-24.13%
Profit Margin
3.60%4.43%11.70%8.76%8.45%-12.10%
FCF Margin
21.26%11.73%2.58%4.28%-1.80%-6.35%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23
Dividend Per Share
0.0700.0700.0500.0500.050
Dividend Per Share Growth
40.00%40.00%0%0%-
Dividend Yield
1.80%1.60%1.16%1.19%1.47%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
85.8468.4518.9622.4720.93-
Forward PE
-95.5595.5595.5595.5595.55
P/FCF Ratio
13.1425.8585.8745.99--
PS Ratio
2.793.032.221.971.772.48